Novelgen
Find Us
← Back to list
Celldex drug stumbles in eczema; Epigenetic editing startup cuts staff

Celldex drug stumbles in eczema; Epigenetic editing startup cuts staff

BioPharma DiveBen FidlerNovember 20, 2026
Wall Street analysts rushed to Celldex s defense following the setback. Elsewhere, Isomorphic Labs cut a cancer-focused deal with Merck and Teva s research chief accepted a new job.
Read original article
← Back to list